Find a Commonwealth Resource
Penicillamine
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Penicillamine is a prescription oral capsule medication containing 250 mg of the active ingredient, classified as an antirheumatic agent. It is manufactured by Actavis Pharma, Inc., and approved under application ANDA210976 for treating conditions like rheumatoid arthritis. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Penicillamine
Access the FDA dataset for Penicillamine — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025